Bethel, M. A. and McMurray, J. J.V. (2018) Class effect for sodium glucose-cotransporter-2 inhibitors in cardiovascular outcomes: implications for the cardiovascular disease specialist. Circulation, 137(12), pp. 1218-1220. (doi: 10.1161/CIRCULATIONAHA.117.030117) (PMID:29555706)
Full text not currently available from Enlighten.
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Keywords: | SGLT-2 inhibitor, canagliflozin, cardiovascular diseases, diabetes mellitus, empagliflozin, mortality, myocardial infarction |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
| Authors: | Bethel, M. A., and McMurray, J. J.V. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Circulation |
| Publisher: | American Heart Association |
| ISSN: | 0009-7322 |
| ISSN (Online): | 1524-4539 |
| Published Online: | 19 March 2018 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details